Grifols (GIKLY) Change in Intangibles (2010 - 2020)

Grifols (GIKLY) posted Change in Intangibles of -$28.9 million for Q1 2020, up 60.41% quarter-over-quarter from -$73.0 million in Q4 2019, and down 54.18% year-on-year from -$63.1 million in Q2 2019.

Grifols (GIKLY) Change in Intangibles (2010 - 2020) Analysis & Trends

Grifols (GIKLY) has reported Change in Intangibles for 10 consecutive years, with -$28.9 million the latest figure, recorded in Q1 2020.

  • Change in Intangibles for Q1 2020 came in at -$28.9 million, down 54.18% year-over-year; the trailing twelve-month figure through Mar 2020 was -$73.9 million (down 373.3% YoY), and the FY2021 annual result was -$77.5 million, up 17.67% from the prior year.
  • Change in Intangibles was -$28.9 million for Q1 2020 at Grifols, up from -$73.0 million in the prior quarter.
  • Over five years, Change in Intangibles peaked at $46.8 million in Q4 2018 and troughed at -$73.0 million in Q4 2019.
  • Average Change in Intangibles over 5 years is -$12.4 million, with a median of -$7.3 million recorded in 2017.
  • Year-over-year, Change in Intangibles plunged 854.1% in 2016 and jumped 364.21% in 2018.
  • Over 5 years, Change in Intangibles stood at -$59.4 million in 2016, then soared by 150.66% to $30.1 million in 2017, then soared by 55.34% to $46.8 million in 2018, then slumped by 256.18% to -$73.0 million in 2019, then jumped by 60.41% to -$28.9 million in 2020.
  • Per Business Quant data, the three most recent Change in Intangibles figures were -$28.9 million in Q1 2020, -$73.0 million in Q4 2019, and -$18.8 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -991.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -461.00 Mn
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -28.91 Mn
Mar 31, 2020 -28.91 Mn
Dec 31, 2019 -73.03 Mn
Dec 31, 2019 -73.03 Mn
Mar 31, 2019 -18.75 Mn
Mar 31, 2019 -18.75 Mn
Dec 31, 2018 46.76 Mn
Dec 31, 2018 46.76 Mn
Jun 30, 2018 -62.47 Mn
Jun 30, 2018 -62.47 Mn
Mar 31, 2018 18.84 Mn
Mar 31, 2018 18.84 Mn
Dec 31, 2017 30.10 Mn
Dec 31, 2017 30.10 Mn
Jun 30, 2017 18.45 Mn
Jun 30, 2017 18.45 Mn
Mar 31, 2017 4.06 Mn
Mar 31, 2017 4.06 Mn
Dec 31, 2016 35.46 Mn
Dec 31, 2016 35.46 Mn